We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,307
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GROW icon
7901
US Global Investors
GROW
$37M
$1K ﹤0.01%
422
-2,368
-85% -$3.82K
GTIM icon
7902
Good Times Restaurants
GTIM
$14.8M
$1K ﹤0.01%
640
-210
-25% -$353
HAIL icon
7903
State Street SPDR S&P Kensho Smart Mobility ETF
HAIL
$19.9M
$1K ﹤0.01%
39
-65
-63% -$1.83K
HDMV icon
7904
First Trust Horizon Managed Volatility Developed International ETF
HDMV
$17.6M
$1K ﹤0.01%
+34
New +$1.15K
HNDL icon
7905
Strategy Shares Nasdaq 7HANDL Index ETF
HNDL
$638M
$1K ﹤0.01%
+21
New +$507
HTAB icon
7906
Hartford Schroders Tax-Aware Bond ETF
HTAB
$289M
$1K ﹤0.01%
+28
New +$590
HTEC icon
7907
ROBO Global Healthcare Technology and Innovation ETF
HTEC
$71M
$1K ﹤0.01%
35
-565
-94% -$14.1K
INDP icon
7908
Indaptus Therapeutics
INDP
$181M
-1
Closed -$1.38K
INUV icon
7909
Inuvo
INUV
$18M
$1K ﹤0.01%
216
-4,816
-96% -$13.6K
IPDN icon
7910
Professional Diversity Network
IPDN
$5.81M
$1K ﹤0.01%
30
-84
-74% -$2.06K
JAKK icon
7911
Jakks Pacific
JAKK
$298M
$1K ﹤0.01%
48
-1,070
-96% -$9.5K
KRKR
7912
36Kr Holdings
KRKR
$5.72M
$1K ﹤0.01%
+9
New +$1.57K
KRMD icon
7913
KORU Medical Systems
KRMD
$195M
$1K ﹤0.01%
+102
New +$497
LINC icon
7914
Lincoln Educational Services
LINC
$1.37B
$1K ﹤0.01%
288
LMFA
7915
DELISTED
LM Funding America
LMFA
$1K ﹤0.01%
+1
New +$632
LRMR icon
7916
Larimar Therapeutics
LRMR
$427M
$1K ﹤0.01%
87
-1,255
-94% -$12K
MAPS
7917
DELISTED
WM TECHNOLOGY INC A
MAPS
$1K ﹤0.01%
+100
New +$988
MARA icon
7918
Marathon Digital Holdings
MARA
$4.48B
$1K ﹤0.01%
+863
New +$1.11K
MDRR
7919
Medalist Diversified Inc
MDRR
$18.5M
$1K ﹤0.01%
20
-133
-87% -$8.46K
MOGU
7920
MOGU Inc
MOGU
$16.7M
$1K ﹤0.01%
27
+18
+200% +$484
MSN icon
7921
Emerson Radio
MSN
$7.72M
$1K ﹤0.01%
1,659
-2,791
-63% -$2.39K
FEED
7922
ENvue Medical Inc
FEED
$2.25M
0
NEON icon
7923
Neonode
NEON
$15.2M
$1K ﹤0.01%
+420
New +$786
NRXPW
7924
DELISTED
NRX Pharmaceuticals Warrant
NRXPW
$1K ﹤0.01%
5,600
+500
+10% +$91
NTIC icon
7925
Northern Technologies International Corp
NTIC
$80.8M
$1K ﹤0.01%
100
-19
-16% -$239

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,307 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.